A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects
Clinical trial NCT02059330 · COMPLETED
Trial details
- NCT number
- NCT02059330
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2014-06-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.